Jason Chin is looking at ways in which proteins can be altered to change their properties, which can create new therapeutics, and even give an insight into what’s going on inside living cells. Chem@Cam, page 8.
LMB In The News
From Genome to Proteome: BCA Winter Meeting 2012
Report on the BCA Winter Meeting, held at LMB in December. Summary of talks, including Chris Oubridge from Kiyoshi Nagai’s group and Israel Sanchez from Venki Ramakrishnan’s group.
100 years from now: Jason Chin on synthetic biology
LMB’s Jason Chin discusses synthetic biology, and where research will take us in the next 100 years, for the Centenary edition of MRC Network, page 26
First glimpse inside the new LMB
As the move into the new LMB building begins, Cambridge News take a look inside at the new facilities. This article is no longer available from the source website: Cambridge News 17 January 2013
Reality check for DNA Nanotechnology
Two major barriers to the advancement of DNA nanotechnology beyond the research lab have been knocked down, in a collaboration between LMB scientists and researchers at Technische Universitaet Muenchen… More…
Bicycle Therapeutics secures £3.75 million investment
Bicycle Therapeutics, an LMB spin out company, is to start work on its first drug candidates after it raised £3.75 million in VC investment, its first funding round in over two and a half years… More…